The Business Research Company’s report on the Blood Platelets Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the blood platelets market?
The increasing prevalence of blood disorders is expected to propel the growth of the blood platelets market going forward. Blood disorders refer to conditions that affect the function, production or components of blood, including red blood cells, white blood cells, platelets or plasma, leading to issues such as anemia, clotting disorders or immune system deficiencies. The increasing prevalence of blood disorders is rising due to the aging population, as aging leads to a decline in bone marrow function, making older adults more susceptible to conditions like anemia, thrombocytopenia, and clotting disorders. Blood platelets enhance blood disorders treatments by regulating blood clotting, making them essential for preventing excessive bleeding and supporting wound healing. For instance, in April 2024, according to the Perth Blood Institute, an Australia-based non-profit organization, the number of people identified with hemophilia (a rare genetic disorder where the blood doesn’t clot properly due to a lack of clotting factor leading to prolonged bleeding) reached 257,146 in 2022, rising from 233,577 in 2021. Therefore, the increasing prevalence of blood disorders is driving the growth of the blood platelets market.
Access Your Free Sample of the Global Blood Platelets Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=23330&type=smp
How has the blood platelets market size evolved, and what are the latest forecasts for its expansion?
The blood platelets market size has grown strongly in recent years. It will grow from $6.27 billion in 2024 to $6.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing number of surgeries, growing incidence of traumatic injuries, 6.27 prevalence of autoimmune diseases, rising incidence of chronic diseases and growing prevalence of thrombocytopenia.
The blood platelets market size is expected to see strong growth in the next few years. It will grow to $8.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to growing number of trauma cases, rise in the number of blood banks, growing preference for allogeneic blood transfusion therapies, increasing aging population, and rise in the need for platelets in wound healing. Major trends in the forecast period include automated platelet apheresis systems, advanced platelet storage technologies, platelet-rich plasma (PRP) therapies, shift toward leukoreduced platelets, artificial platelet substitutes, gene editing for platelet disorders and automated donor screening.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=23330&type=smp
Which major companies dominate the blood platelets market?
Major companies operating in the blood platelets market are Pfizer Inc., Johnson & Johnson, Bayer AG, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma Inc., LFB Group, Bio Products Laboratory Limited, Sanquin, Macopharma, Biotest AG, Cerus Corporation, ADMA Biologics Inc., Octapharma AG, Kamada Ltd., HemaCare
What trends will shape the future of the blockchain in telecom market?
Major companies operating in the blood platelet market are focusing on developing innovative solutions, such as platelet pooling to extend shelf life, enhance availability, and support blood centers in meeting growing transfusion demands. Platelet pooling refers to the process of combining platelets from multiple whole blood donations to create a single platelet unit for transfusion, improving availability, efficiency, and resource utilization in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. The innovation extends the shelf life of whole blood-derived platelets from five to seven days, enhancing platelet availability for transfusion. It also provides an alternative source of platelet supply to address rising demand and donor shortages, helping blood centers improve inventory management and reduce waste.
Which region dominates the blood platelets market, and what factors contribute to its leadership?
North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood platelets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report
How is the blood platelets market segmented, and which segment holds the largest share?
The blood platelets market covered in this report is segmented –
1) By Platelet Type: Whole Blood Derived Platelets, Apheresis Derived Platelets
2) By Application: Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication
3) By End-Users: Hospitals, Ambulatory Surgical Centers, Blood Banks, Research Laboratories, Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users
Subsegments:
1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets, Non-Leukocyte-Reduced Whole Blood Platelets, Pathogen-Reduced Whole Blood Platelets
2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets, Leukocyte-Reduced Apheresis Platelets, Pathogen-Reduced Apheresis Platelets
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23330
What defines the structure and scope of the blood platelets market?
Blood platelets, also known as thrombocytes are small, disc-shaped cell fragments in the blood that help in clot formation and wound healing. They prevent excessive bleeding adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent excessive blood loss. They are produced in the bone marrow and are essential for hemostasis and blood vessel repair.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
